Remifentanil mimics cardioprotective effect of ischemic preconditioning via protein kinase C activation in open chest of rats

Acta Pharmacologica Sinica

Volumn 26, Issue 5, 2005, Pages 546-550

  Zhang, Ye ^a,b   Chen, Zhi Wu ^a   Irwin, Michael G ^b   Wong, Tak Ming ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chelerythrine; GF109203X; Myocardial ischemia preconditioning; Myocardial reperfusion injury; Protein kinase C; Remifentanil

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CHELERYTHRINE; INOSITOL 1,4,5 TRISPHOSPHATE; NALTRINDOLE; NORBINALTORPHIMINE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; REMIFENTANIL; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMICS; HIGH RISK PATIENT; NONHUMAN; RAT; RECEPTOR BLOCKING; REPERFUSION INJURY;

ALKALOIDS; ANIMALS; BENZOPHENANTHRIDINES; CARDIOTONIC AGENTS; HEMODYNAMIC PROCESSES; INDOLES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MALEIMIDES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHENANTHRIDINES; PIPERIDINES; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY;

EID: 18744383380     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00100.x     Document Type: Article

References (22)

1. Schultz JE, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996; 78: 1100-4.
2. Schultz JJ, Hsu AK, Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J Mol Cell Cardiol 1997; 29: 2187-95.
3. ATP channel linked mechanisms in rats. Br J Anaesth 2000; 84: 204-14.
4. Kato R, Foex P. Fentanyl reduces infarction but not stunning via delta-opioid receptors and protein kinase C in rats. Br J Anaesth 2000; 84: 608-14.
5. Zhang Y, Irwin M, Wong TM. Remifentanil preconditioning protects against ischemic injury in the intact rat heart. Anesthesiology 2004; 101: 918-23.
6. James MK, Feldman PL, Schuster SV, Bilotta JM, Brackeen MF, Leighton HJ. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991; 259: 712-8.
7. Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, Shafer SL. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996; 84: 821-33.
8. Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther 2001; 89: 123-37.
9. Gross GJ. Role of opioids in acute and delayed preconditioning. J Mol Cell Cardiol 2003; 35: 709-18.
10. Miki T, Cohen MV, Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 1998; 186: 3-12.
11. Fryer RM, Schultz JE, Hsu AK, Gross GJ. Pretreatment with tyrosine kinase inhibitors partially attenuates ischemic preconditioning in rat hearts. Am J Physiol 1998; 275: H2009-15.
12. Fryer RM, Wang Y, Hsu AK, Gross GJ. Essential activation of PKC-delta in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol 2001; 280: H1346-53.
13. Schultz JE, Hsu AK, Gross GJ. Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors. Circulation 1998; 97: 1282-9.
14. Wang GY, Wu S, Pei JM, Yu XC, Wong TM. Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol Heart Circ Physiol 2001; 280: H384-91.
15. Aghajanian GK, Wang YY. Pertussis toxin blocks the outward currents evoked by opiate and alpha 2-agonists in locus coeruleus neurons. Brain Res 1986; 371: 390-4.
16. Burns DL, Hewlett EL, Moss J, Vaughan M. Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108-15 cells. J Biol Chem 1983; 258: 1435-8.
17. 2+ release from an intracellular pool in myocytes and neurons. Cire Res 1992; 70: 66-81.
18. Cao CM, Xia Q, Tu J, Chen M, Wu S, Wong TM. Cardioprotection of interleukin-2 is mediated via {kappa}-opioid receptors. J Pharmacol Exp Ther 2004; 309: 560-7.
19. Wu S, Li HY, Wong TM. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ Res 1999; 84: 1388-95.
20. Armstrong SC. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 2004; 61: 427-36.
21. Simkhovich BZ, Przyklenk K, Kloner RA. Role of protein kinase C as a cellular mediator of ischemic preconditioning: a critical review. Cardiovasc Res 1998; 40: 9-22.
22. Zaugg M, Lucchinetti E, Uecker M, Pasch T, Schaub MC. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth 2003; 91: 551-65.